A global leader in biomarker services
Synexa Life Sciences is a specialist biomarker services provider, with deep expertise in the design and delivery of biomarker strategies for global biopharma clients.
Our services include:
- Advice on the optimal selection of biomarkers in the context of the drug, disease and budget.
- Development, validation and optimization of biomarker assays in a wide range of matrices.
- Biomarker analysis of clinical samples, across a wide range of leading edge platforms.
- Interpretation of results and advice on key decisions to be made about candidate therapies.
Synexa is headquartered in the Leiden Bio Science Park in the Netherlands, and has over 50 scientists in three main laboratories in London, Berlin and Cape Town. These professional scientists operate in client-focused teams with an emphasis on scientific collaboration and problem solving.
Synexa's services and technology platforms cover the full spectrum of biomarker types, including DNA, RNA, protein, cellular and tissue analysis. The company also offers an innovative approach to translational immunology, liquid biopsy analysis and bioinformatics-driven patient stratification.